SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012056
Filing Date
2020-08-07
Accepted
2020-08-06 18:05:27
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aeri-20200630.htm   iXBRL 10-Q 1701130
2 AERI 6.30.2020 EX-31.1 aeri6302020ex311.htm EX-31.1 16304
3 AERI 6.30.2020 EX-31.2 aeri6302020ex312.htm EX-31.2 16299
4 AERI 6.30.2020 EX-32.1 aeri6302020ex321.htm EX-32.1 10485
5 AERI 6.30.2020 EX-32.2 aeri6302020ex322.htm EX-32.2 10427
  Complete submission text file 0001628280-20-012056.txt   7084684

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20200630.xsd EX-101.SCH 38514
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20200630_cal.xml EX-101.CAL 63928
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20200630_def.xml EX-101.DEF 199645
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20200630_lab.xml EX-101.LAB 527458
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20200630_pre.xml EX-101.PRE 338267
11 EXTRACTED XBRL INSTANCE DOCUMENT aeri-20200630_htm.xml XML 1324877
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 201083106
SIC: 2836 Biological Products, (No Diagnostic Substances)